Cargando…

Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia

Detalles Bibliográficos
Autores principales: Herman, SEM, Barr, PM, McAuley, EM, Liu, D, Wiestner, A, Friedberg, JW
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920486/
https://www.ncbi.nlm.nih.gov/pubmed/23385377
http://dx.doi.org/10.1038/leu.2013.37
_version_ 1782303177788358656
author Herman, SEM
Barr, PM
McAuley, EM
Liu, D
Wiestner, A
Friedberg, JW
author_facet Herman, SEM
Barr, PM
McAuley, EM
Liu, D
Wiestner, A
Friedberg, JW
author_sort Herman, SEM
collection PubMed
description
format Online
Article
Text
id pubmed-3920486
institution National Center for Biotechnology Information
language English
publishDate 2013
record_format MEDLINE/PubMed
spelling pubmed-39204862014-02-11 Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia Herman, SEM Barr, PM McAuley, EM Liu, D Wiestner, A Friedberg, JW Leukemia Article 2013-02-06 2013-08 /pmc/articles/PMC3920486/ /pubmed/23385377 http://dx.doi.org/10.1038/leu.2013.37 Text en Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Herman, SEM
Barr, PM
McAuley, EM
Liu, D
Wiestner, A
Friedberg, JW
Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia
title Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia
title_full Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia
title_fullStr Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia
title_full_unstemmed Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia
title_short Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia
title_sort fostamatinib inhibits b-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920486/
https://www.ncbi.nlm.nih.gov/pubmed/23385377
http://dx.doi.org/10.1038/leu.2013.37
work_keys_str_mv AT hermansem fostamatinibinhibitsbcellreceptorsignalingcellularactivationandtumorproliferationinpatientswithrelapsedandrefractorychroniclymphocyticleukemia
AT barrpm fostamatinibinhibitsbcellreceptorsignalingcellularactivationandtumorproliferationinpatientswithrelapsedandrefractorychroniclymphocyticleukemia
AT mcauleyem fostamatinibinhibitsbcellreceptorsignalingcellularactivationandtumorproliferationinpatientswithrelapsedandrefractorychroniclymphocyticleukemia
AT liud fostamatinibinhibitsbcellreceptorsignalingcellularactivationandtumorproliferationinpatientswithrelapsedandrefractorychroniclymphocyticleukemia
AT wiestnera fostamatinibinhibitsbcellreceptorsignalingcellularactivationandtumorproliferationinpatientswithrelapsedandrefractorychroniclymphocyticleukemia
AT friedbergjw fostamatinibinhibitsbcellreceptorsignalingcellularactivationandtumorproliferationinpatientswithrelapsedandrefractorychroniclymphocyticleukemia